Neuropsychiatric Disorder Cluster Drug Development Pipeline Review : Status, Size, Share, Trends and Application 2017
ResearchMoz presents professional and in-depth study of "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017". This report provides an overview of the pipeline landscape for neuropsychiatric disorders . The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant and discontinued projects. Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness, with symptoms including disorganized work habits, procrastination and inability to sustain attention on tasks or activities. Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anx...